11 pending office actions • 9 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (9%) |
| §103 only | 4 (36%) |
| §112 only | 1 (9%) |
| Double-patenting + other | 1 (9%) |
| Multi-statute (no §101) | 4 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NEDIALKOVA, LILIA V | 1 | 55.3% | +22.4% |
| LIN, KO-WEI | 1 | 75.8% | +20.4% |
| DWIVEDI, MAHESH H | 1 | 69.6% | +4.3% |
| JEONG, YOUNGSUL | 1 | 71.6% | +21.2% |
| GROOMS, TIFFANY NICOLE | 1 | 58.8% | +46.8% |
| SULLIVAN, DENNIS JOHN | 1 | 61.1% | +47.4% |
| HUI, SAN MING R | 1 | 59.3% | +20.0% |
| HOEKSTRA, JEFFREY GERBEN | 1 | 55.7% | +39.6% |
| THUESON, HANNA MARIE | 1 | 77.3% | +26.5% |
| OGUNTADE, ELIZABETH BISOLA | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17730337 | AUTOMATED FLUIDIC ASSAY BASED ON MOLECULARLY IMPRINTED POLYMER FOR DETECTION OF ANTIBODIES AND PROTEINS IN BODY FLUIDS | OGUNTADE, ELIZABETH BISOLA | 16d |
| 18085700 | VENTRAL STRIATUM ACTIVITY | HOEKSTRA, JEFFREY GERBEN | 72d |
| 18685334 | METHOD OF PRODUCING GARNET-TYPE SOLID ELECTROLYTES | NEDIALKOVA, LILIA V | — |
| 18294356 | METHODS AND SYSTEMS FOR SELECTING ACTIONS FROM A SET OF ACTIONS TO BE PERFORMED IN AN ENVIRONMENT AFFECTED BY DELAYS | DWIVEDI, MAHESH H | — |
| 17581320 | LOW PRESSURE CARBONATION CURING OF CONCRETE ELEMENTS AND PRODUCTS IN AN EXPANDABLE ENCLOSURE | ABU ALI, SHUANGYI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18102296 | ADMINISTRATION OF MODULATORS OF 5-HT AND / OR AMPA RECEPTORS FOR TREATING NEUROLOGICAL CONDITIONS | HUI, SAN MING R | 21d |
| 18054292 | POROUS DOUBLE-NETWORK HYDROGEL | THUESON, HANNA MARIE | 22d |
| 18085700 | VENTRAL STRIATUM ACTIVITY | HOEKSTRA, JEFFREY GERBEN | 72d |
| 18685334 | METHOD OF PRODUCING GARNET-TYPE SOLID ELECTROLYTES | NEDIALKOVA, LILIA V | — |
| 18683611 | SYSTEM FOR SELF-SUSTAINING COMBUSTION OF IRON PARTICLES AND METHOD THEREOF | LIN, KO-WEI | — |
| 18264668 | FIBER-BASED MATERIALS FOR WATER TREATMENT | JEONG, YOUNGSUL | — |
| 18344507 | OLIGONUCLEOTIDES CONTAINING 2'-DEOXY-2'FLUORO-BETA-D-ARABINOSE NUCLEIC ACID (2'-FANA) FOR TREATMENT AND DIAGNOSIS OF RETROVIRAL DISEASES | GROOMS, TIFFANY NICOLE | — |
| 18255682 | THERAPEUTIC APPLICATIONS OF TYPE 1 INSULIN-LIKE GROWTH FACTOR (IGF-1) RECEPTOR ANTAGONISTS | SULLIVAN, DENNIS JOHN | — |
| Art Unit | Apps |
|---|---|
| 3762 | 1 |
| 1772 | 1 |
| 1637 | 1 |
| 1642 | 1 |
| 1627 | 1 |
| 3791 | 1 |
| 1600 | 1 |
| 1677 | 1 |
| 1731 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18685334 | METHOD OF PRODUCING GARNET-TYPE SOLID ELECTROLYTES | NEDIALKOVA, LILIA V | — | §102§103§112 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18683611 | SYSTEM FOR SELF-SUSTAINING COMBUSTION OF IRON PARTICLES AND METHOD THEREOF | LIN, KO-WEI | 3762 | §112 | Final Rejection | — | Pending | Feb 14, 2024 |
| 18294356 | METHODS AND SYSTEMS FOR SELECTING ACTIONS FROM A SET OF ACTIONS TO BE PERFORMED IN AN ENVIRONMENT AFFECTED BY DELAYS | DWIVEDI, MAHESH H | — | §101§103 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18264668 | FIBER-BASED MATERIALS FOR WATER TREATMENT | JEONG, YOUNGSUL | 1772 | §103 | Final Rejection | — | Pending | Aug 08, 2023 |
| 18344507 | OLIGONUCLEOTIDES CONTAINING 2'-DEOXY-2'FLUORO-BETA-D-ARABINOSE NUCLEIC ACID (2'-FANA) FOR TREATMENT AND DIAGNOSIS OF RETROVIRAL DISEASES | GROOMS, TIFFANY NICOLE | 1637 | §103 | Non-Final OA | — | Pending | Jun 29, 2023 |
| 18255682 | THERAPEUTIC APPLICATIONS OF TYPE 1 INSULIN-LIKE GROWTH FACTOR (IGF-1) RECEPTOR ANTAGONISTS | SULLIVAN, DENNIS JOHN | 1642 | §103§112DPOther | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18102296 | ADMINISTRATION OF MODULATORS OF 5-HT AND / OR AMPA RECEPTORS FOR TREATING NEUROLOGICAL CONDITIONS | HUI, SAN MING R | 1627 | §103 | Final Rejection | 21d | Pending | Jan 27, 2023 |
| 18085700 | VENTRAL STRIATUM ACTIVITY | HOEKSTRA, JEFFREY GERBEN | 3791 | §102§112 | Final Rejection | 72d | Pending | Dec 21, 2022 |
| 18054292 | POROUS DOUBLE-NETWORK HYDROGEL | THUESON, HANNA MARIE | 1600 | §103 | Non-Final OA | 22d | Pending | Nov 10, 2022 |
| 17730337 | AUTOMATED FLUIDIC ASSAY BASED ON MOLECULARLY IMPRINTED POLYMER FOR DETECTION OF ANTIBODIES AND PROTEINS IN BODY FLUIDS | OGUNTADE, ELIZABETH BISOLA | 1677 | §103§112 | Final Rejection | 16d | Pending | Apr 27, 2022 |
| 17581320 | LOW PRESSURE CARBONATION CURING OF CONCRETE ELEMENTS AND PRODUCTS IN AN EXPANDABLE ENCLOSURE | ABU ALI, SHUANGYI | 1731 | §102§103 | Final Rejection | — | Pending | Jan 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial